Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
LICN Stock Forecast 2025-2026
$4.07
Current Price
$66.45M
Market Cap
Buy 0
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to LICN Price Targets
N/A
To High Target of $N/A
N/A
To Median Target of $N/A
N/A
To Low Target of $N/A
LICN Price Momentum
+35.2%
1 Week Change
+13.1%
1 Month Change
+730.6%
1 Year Change
+2,161.1%
Year-to-Date Change
-77.4%
From 52W High of $18.00
+11,205.6%
From 52W Low of $0.04
📊 TOP ANALYST CALLS
Did LICN Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Lichen China is one of their latest high-conviction picks.
Latest LICN Stock Price Targets & Analyst Predictions
LICN has shown a year-to-date change of 2,161.1% and a 1-year change of 730.6%, reflecting upward momentum over the past year. Comprehensive analyst forecasts are currently unavailable for LICN. Please refer to the price chart above for recent performance and trends.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
LICN Analyst Ratings
0
Buy
0
Hold
0
Sell
LICN Price Target Range
Low
N/A
Average
N/A
High
N/A
Current: $4.07
Latest LICN Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for LICN.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|
Lichen China Ltd. (LICN) Competitors
The following stocks are similar to Lichen China based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
LICN
Lichen China
mkt cap
66.45M
Lichen China Ltd. (LICN) Financial Data
Lichen China Ltd. has a market capitalization of $66.45M with a P/E ratio of 0.1x. The company generates $37.64M in trailing twelve-month revenue with a -43.2% profit margin.
Revenue growth is -21.2% quarter-over-quarter, while maintaining an operating margin of -36.8% and return on equity of -24.0%.
Valuation Metrics
Market Cap
$66.45M
Enterprise Value
$-19,115,372
P/E Ratio
0.1x
PEG Ratio
N/A
Price/Sales
1.8x
Growth & Margins
Revenue Growth (YoY)
-21.2%
Gross Margin
N/A
Operating Margin
-36.8%
Net Margin
-43.2%
EPS Growth
N/A
Financial Health
Cash/Price Ratio
+728.0%
Current Ratio
10.2x
Debt/Equity
0.6x
ROE
-24.0%
ROA
-10.3%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Lichen China Ltd. (LICN) Business Model
About Lichen China Ltd.
What They Do
Provides consulting and financial advisory services.
Business Model
The company generates revenue by offering business consulting, financial, and tax advisory services specifically tailored for small and medium-sized enterprises (SMEs) in China. It supports these businesses in navigating complex regulatory frameworks and optimizing their financial strategies, thereby enhancing their operational efficiency and growth potential.
Additional Information
Lichen China Ltd. has a strong focus on sectors such as manufacturing, technology, and retail, leveraging its local market expertise and extensive industry network. Its role is particularly vital in the rapidly evolving Chinese economy, where it aids SMEs in compliance and strategic financial planning.
Company Information
Sector
Industrials
Industry
Specialty Business Services
Employees
452
CEO
Mr. Ya Li
Country
China
IPO Year
2023
Website
www.lichenzx.comLichen China Ltd. (LICN) Latest News & Analysis
Latest News
Quick Summary
Lichen China Limited (Nasdaq: LICN) announced a reverse stock split of its ordinary shares, with details on the effectiveness date and ratio to follow. Shareholder voting results were disclosed on February 12, 2025.
Why It Matters
Lichen China's reverse stock split can impact share price and liquidity, signaling potential restructuring efforts, which may affect investor sentiment and valuation.
Source: PRNewsWire
Market Sentiment:
Neutral
Lichen China Limited Announces Receipt of Nasdaq Delisting Notice Subject to Hearing Request
9 months ago
Quick Summary
Lichen China Limited (Nasdaq: LICN) faces delisting from Nasdaq due to a closing bid price of $0.10 or lower for eleven consecutive trading days, as per Nasdaq Listing Rule 5810(c)(3)(A)(iii).
Why It Matters
Lichen China Limited faces potential delisting from Nasdaq due to low stock prices, which may significantly impact investor confidence and liquidity in the company's shares.
Source: PRNewsWire
Market Sentiment:
Neutral
Quick Summary
Lichen China Limited (NASDAQ: LICN) has completed its acquisition of the remaining 40% of Bondly Enterprises, enhancing its capabilities in business process management and AI integration.
Why It Matters
Lichen China's full acquisition of Bondly enhances its technological capabilities and market position, potentially leading to increased revenue and operational efficiency, which can boost investor confidence.
Source: PRNewsWire
Market Sentiment:
Neutral
Quick Summary
Univest Securities announced a registered direct offering for Lichen China Limited (NASDAQ: LICN), a financial and taxation service provider.
Why It Matters
The registered direct offering by Lichen China Limited may dilute existing shares, impacting stock value. Investors should monitor the company's financial health and market reaction.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Lichen China Limited (Nasdaq: LICN) received a notification from Nasdaq that its share price has been below $1.00 for 30 consecutive business days, risking its continued listing.
Why It Matters
Lichen China Limited risks delisting from Nasdaq due to a share price below $1 for 30 days, potentially impacting investor confidence and market liquidity.
Source: PRNewsWire
Market Sentiment:
Neutral
Quick Summary
Lichen China Limited has agreed to a direct offering of 42.5 million Class A shares at $0.08 each, totaling $3.4 million, with pre-funded warrants available at the same price.
Why It Matters
Lichen China's agreement to sell 42.5 million shares at $0.08 indicates capital raising efforts, potentially impacting liquidity and stock valuation, which can influence investor sentiment.
Source: PRNewsWire
Market Sentiment:
Neutral
Frequently Asked Questions About LICN Stock
What is Lichen China Ltd.'s (LICN) stock forecast for 2026?
Analyst forecasts for Lichen China Ltd. (LICN) are not currently available. The stock is trading at $4.07.
Is LICN stock a good investment in 2026?
Analyst ratings for LICN are not currently available. The stock is currently trading at $4.07. Investment decisions should be based on thorough research and your personal financial goals. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for LICN stock?
Price predictions from Wall Street analysts for LICN are not currently available. The stock is trading at $4.07.
What is Lichen China Ltd.'s business model?
The company generates revenue by offering business consulting, financial, and tax advisory services specifically tailored for small and medium-sized enterprises (SMEs) in China. It supports these businesses in navigating complex regulatory frameworks and optimizing their financial strategies, thereby enhancing their operational efficiency and growth potential.
What is the highest forecasted price for LICN Lichen China Ltd.?
Price targets from Wall Street analysts for LICN are not currently available. The stock is trading at $4.07.
What is the lowest forecasted price for LICN Lichen China Ltd.?
Price targets from Wall Street analysts for LICN are not currently available. The stock is trading at $4.07.
What is the overall LICN consensus from analysts for Lichen China Ltd.?
Analyst ratings for LICN are not currently available. The stock is trading at $4.07.
How accurate are LICN stock price projections?
Stock price projections, including those for Lichen China Ltd., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: December 8, 2025 2:03 PM UTC